Clinical Endocrinology · 1978 · 112 citations · 22 references
MedicineEndocrinologyPharmacologyClinical PharmacologyNeuropharmacologyPsychopharmacologyAntithyroid DrugsThyroid DisordersThyroid EndocrinologyThyroid Hormone BiochemistryThyroid Uptake StudiesAnticonvulsant ActionAnticonvulsant DrugsHormone Metabolism AlterationSerum Thyroid-stimulating Hormone MeasurementThyroid Drug InteractionsThyroid Function TestingThyroid Function TestsThyroid-stimulating Hormone Testing
Thyroid function tests were studied in patients undergoing long-term treatment with various anticonvulsant drugs. Previous reports that diphenylhydantoin induces a decrease in the serum concentrations of total and free thyroxine (T4) and triiodothyronine (T3) without a change in the TSH concentration were confirmed. Diphenylhydantoin had no effect on reverse T3. Carbamazepine was also found to decrease serum T4, the free T4 index and T3 but, with the exception of T3, the decrease was smaller than that induced by diphenylhydantoin. Dipropylacetic acid did not influence the serum thyroid hormone concentrations, and neither did primidone. This demonstrates that the interaction between anticonvulsant drugs of different chemical structure and thyroid hormone metabolism is diverse. None of the drugs tested altered serum TSH or the T3 uptake test for the estimation of unsaturated thyroid hormone binding-capacity in serum. These two tests are considered diagnostically more dependable than the measurement of thyroid hormones in serum when diphenylhydantoin and carbamazepine are administered.
22
INDER J. CHOPRA, Usha Chopra, M. S. Reza et al. · The Journal of Clinical Endocrinology & Metabolism · 1975 · 428 citations
The effect of diphenylhydantoin on thyroxine metabolism in man
P R Larsen, Arthur J. Atkinson, H. N. Wellman et al. · Journal of Clinical Investigation · 1970 · 120 citations · Full text